Drug Combo Granted Priority Review for Untreated Follicular Lymphoma
The FDA has granted Priority Review to Celgene ’s application for lenalidomide in combination with rituximab for previously untreated follicular lymphoma.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Leah Lawrence Source Type: news